BOCA RATON, Fla., Nov. 27, 2024 (GLOBE NEWSWIRE) -- FlexShopper, Inc. (Nasdaq: FPAY) (the “Corporation”) announced today the tentative calendar for its previously proposed rights offering (“Rights Offering”). The Corporation is planning to commence the Rights Offering to raise capital to equitize its balance sheet through funding the repurchase of over 90% of its Series 2 Convertible Preferred Stock, by repaying a portion of its credit facility and other outstanding debt facilities, and for other corporate ...

Shares of Airbnb (ABNB -0.89%) have struggled lately, but the business is still growing and management is expanding into new markets. In this video, Travis Hoium highlights the strategy, growth prospects, and risks behind Airbnb's business.*Stock prices used were end-of-day prices of Nov. 26, 2024. The video was published on Nov. 27, 2024. ...

PHILADELPHIA, Nov. 27, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Steven Kelly, President and Chief Executive Officer, will participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on Thursday, December 5th at 9:35 am ET.An audio webcast of the event will be available on the Company's Investor Events sect ...

– Norbert Bischofberger, Ph.D., is stepping down from his role as President & CEO – – Deborah Knobelman, Ph.D., COO & CFO, is named President & Interim CEO – SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company developing small molecule therapeutics to address cancers and other diseases driven by deregulated transcription, today announced that its Board of Directors has appointed Deborah Knobelman, Ph.D., as President and Interim Chief Executiv ...

WILMINGTON, Del., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens JMP Securities Hematology and Oncology Summit, taking place virtually on December 2, 2024. On Monday, December 2, at 11:30 a.m. ET, Kris Vaddi, Ph.D., Chief Executive Officer of Prelude, and Jane Huang, M.D., President and Chief Medical Officer, will participate in a fireside chat. A live ...

Textron Inc.’s (TXT) , business unit, Textron Aviation Defense, recently delivered five Beechcraft T-6C Texan II planes to Vietnam Air Force, marking a historic milestone. These planes will support pilot training for the Vietnam Air Defense Air Force and strengthen the United States-Vietnam partnership.This delivery comes as part of a contract for a total of 12 planes, ordered in August 2022. The remaining seven aircraft are expected to be delivered by mid-2025.What’s Favoring TXT?As nations across the glob ...

Kristian Flaten, CFO in IDEX Biometrics ASA, has today bought 1,000,000 shares in IDEX Biometrics ASA, at an average price of NOK 0.1180 per share. After this transaction, Flaten owns 1,000,000 shares in IDEX Biometrics ASA. Please refer to the attached notification of trading for further details. For further information contact:Marianne Bøe, Head of Investor RelationsKristian Flaten, CFOE-mail: ir@idexbiometrics.comTel: + 47 67 83 91 19 About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX) is a global techn ...

Bargains in both the artificial intelligence (AI) and chip sectors are hard to come by. Investor enthusiasm in this area has been high for nearly two years, and the results have paid off well.However, one of the most important companies in both spaces is now down around 40% from its all-time high, and it looks like a good value at these levels. So what's this company that's so vital in both spaces?It's Netherlands-based ASML (ASML -1.83%). Let's learn more.Nobody else has ASML's technological capabilitiesAS ...

SAN DIEGO, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Wolfspeed, Inc. (NYSE: WOLF) securities between August 16, 2023 and November 6, 2024, inclusive (the “Class Period”), have until Friday, January 17, 2025 to seek appointment as lead plaintiff of the Wolfspeed class action lawsuit. Captioned Zagami v. Wolfspeed, Inc., No. 24-cv-01395 (N.D.N.Y.), the Wolfspeed class action lawsuit charges Wolfspeed and certain of Wolfspeed’s top executives w ...

核心观点 - Camtek Ltd. 宣布其新产品 Hawk 在正式发布前已收到超过 5000 万美元的初始订单，预计将于 2025 年 2 月在 Semicon Korea 正式发布 [1][4] 产品介绍 - Hawk 基于全新的平台，针对高端先进封装技术，包括对具有 5 亿微凸点和混合键合技术的晶圆进行检测和 3D 测量 [2] - Hawk 产品线解决了行业中最苛刻的应用，包括高带宽内存 (HBM)、Chiplet 和混合键合，以及 Camtek 之前未服务的用例 [3] - Hawk 平台具有无与伦比的吞吐量和精度，旨在满足当前和未来的行业路线图，为检测和计量设定了新的基准 [3] 市场反应 - Camtek 的 CEO Rafi Amit 表示，Hawk 产品线是 Camtek 产品组合的重要补充，并对其在发布前收到的超过 5000 万美元的订单表示满意 [4] - 这些订单反映了市场对这些解决方案的强劲需求，并体现了客户对 Camtek 产品的信心 [4] 公司背景 - Camtek 是一家开发和制造高端检测和计量设备的公司，服务于半导体行业 [5] - Camtek 的系统在半导体器件生产过程中对晶圆进行检测和测量，覆盖前端和中期以及装配开始前的阶段 [5] - Camtek 的系统服务于包括先进互连封装、异构集成、内存和 HBM、CMOS 图像传感器、复合半导体、MEMS 和 RF 在内的最苛刻的半导体市场细分领域 [5] - Camtek 在以色列和德国设有制造工厂，并在全球设有八个办事处，提供符合客户要求的先进解决方案 [6]